Evidence indicates that circulating levels and adipose tissue production of Gal-3 are elevated in obesity in both humans and experimental animals, with higher expression in VAT compared to subcutaneous adipose tissue (SAT) [10], [13], [14]. The gene discussed is LGALS3; the disease is obesity disorder.